SAN FRANCISCO– Komodo Health today announced the launch of two powerful software solutions that provide real-time intelligence in just a few clicks, tapping into 325 million real-world patient journeys for an unparalleled depth and breadth of insight. Prism and Sentinel allow stakeholders across Healthcare and Life Sciences to leverage the industry’s largest and most complete database of de-identified, real-world patient data – along with their own proprietary data – to develop insights and algorithms based on detailed patient behaviors and treatment patterns with an unprecedented level of precision, ease, and flexibility.
Prism and Sentinel are powering the next generation of machine-learning innovation to solve complex challenges, like pinpointing rare disease signals or identifying underserved cancer patients. The software has already been used by more than 30 Komodo Health clients, including large and small life sciences companies and consultancies. Use cases have included commercial strategy, market engagement, clinical development, and health economics and outcomes research for therapeutic areas ranging from ultra-rare diseases to oncology and COVID-19 vaccines.
“Digital transformation is only going to accelerate in Life Sciences, but the industry has been bogged down by archaic and unreliable data,” said Arif Nathoo, MD, CEO and co-founder of Komodo Health. “These new applications offer end-to-end, cloud-based solutions that combine the best data and technology to derive insights quickly, opening up compelling new opportunities for our clients to innovate.”
